Alexandre Theron Shares The Proposals from SFTH on the Implementation of Prophylactic Treatments in Children With Hemophilia
Alexandre Theron, Head of the Pediatric Bone Marrow Transplant and Cell Therapy Unit at CHU Montpellier, shared on LinkedIn:
”We are pleased to announce the publication of the proposals of the SFTH (French Society of Thrombosis and Hemostasis) Paediatricians’ Club on the implementation of prophylactic treatments in children with hemophilia in 2025.
Work carried out with:
Olivia Pineau, Sandrine Meunier, Bayart Sophie, Caroline Oudot and all the members of the club and the support of the SFTH”
Read the full article here.
Article: How to start prophylaxis in untreated children with severe and moderate haemophilia in 2025, opinion of paediatricians from the French Society of Thrombosis and Haemostasis
Authors: Alexandre Theron, Olivia Pineau, Sophie Bayart, Caroline Oudot, Sandrine Meunier
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
May 30, 2026, 10:36Saman Adnan: New Research Explores Readmission Risk in Brain Cancer Patients With VTE
-
May 30, 2026, 10:27Sartaj Alam: CBC Analyzer – The Backbone of Modern Hematology Diagnostics
-
May 30, 2026, 10:17Factor X Deficiency – From Mild Bruising to Life Threatening Hemorrhage – ICHCC
-
May 30, 2026, 10:06Johann Morelle: Complement Inhibitors Are Reshaping Modern Nephrology
-
May 30, 2026, 09:49Flora Peyvandi: Exploring a Multidisciplinary Care Model for Hemophilia and Rare Diseases
-
May 30, 2026, 08:59Li-Chia Chen: Advancing Patient Care Through Pharmacist Innovation at KUTRRH
-
May 30, 2026, 08:58Ben Creagh-Brown: How Should HI-PEITHO Influence the Management of Intermediate-Risk Pulmonary Embolism?
-
May 30, 2026, 08:56Reidiel Suárez Borges: Understanding the INR in Anticoagulation Management
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products